Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2006 1
2007 1
2008 2
2010 1
2011 2
2012 2
2013 1
2014 3
2015 3
2016 3
2017 2
2018 7
2019 3
2020 8
2021 12
2022 9
2023 10
2024 3

Text availability

Article attribute

Article type

Publication date

Search Results

67 results

Results by year

Filters applied: . Clear all
Page 1
Antimicrobial for 7 or 14 Days for Febrile Urinary Tract Infection in Men: A Multicenter Noninferiority Double-Blind, Placebo-Controlled, Randomized Clinical Trial.
Lafaurie M, Chevret S, Fontaine JP, Mongiat-Artus P, de Lastours V, Escaut L, Jaureguiberry S, Bernard L, Bruyere F, Gatey C, Abgrall S, Ferreyra M, Aumaitre H, Aparicio C, Garrait V, Meyssonnier V, Bourgarit-Durand A, Chabrol A, Piet E, Talarmin JP, Morrier M, Canoui E, Charlier C, Etienne M, Pacanowski J, Grall N, Desseaux K, Empana-Barat F, Madeleine I, Bercot B, Molina JM, Lefort A; PROSTASHORT Study Group. Lafaurie M, et al. Among authors: de lastours v. Clin Infect Dis. 2023 Jun 16;76(12):2154-2162. doi: 10.1093/cid/ciad070. Clin Infect Dis. 2023. PMID: 36785526 Clinical Trial.
Discontinuing β-lactam treatment after 3 days for patients with community-acquired pneumonia in non-critical care wards (PTC): a double-blind, randomised, placebo-controlled, non-inferiority trial.
Dinh A, Ropers J, Duran C, Davido B, Deconinck L, Matt M, Senard O, Lagrange A, Makhloufi S, Mellon G, de Lastours V, Bouchand F, Mathieu E, Kahn JE, Rouveix E, Grenet J, Dumoulin J, Chinet T, Pépin M, Delcey V, Diamantis S, Benhamou D, Vitrat V, Dombret MC, Renaud B, Perronne C, Claessens YE, Labarère J, Bedos JP, Aegerter P, Crémieux AC; Pneumonia Short Treatment (PTC) Study Group. Dinh A, et al. Among authors: de lastours v. Lancet. 2021 Mar 27;397(10280):1195-1203. doi: 10.1016/S0140-6736(21)00313-5. Lancet. 2021. PMID: 33773631 Clinical Trial.
Immunomodulators for immunocompromised patients hospitalized for COVID-19: a meta-analysis of randomized controlled trials.
Siempos II, Kalil AC, Belhadi D, Veiga VC, Cavalcanti AB, Branch-Elliman W, Papoutsi E, Gkirgkiris K, Xixi NA, Kotanidou A, Hermine O, Porcher R, Mariette X; CORIMUNO-19 Collaborative Group; DisCoVeRy Study Group; ACTT-2 Study Group; ACTT-3 Study Group. Siempos II, et al. EClinicalMedicine. 2024 Feb 9;69:102472. doi: 10.1016/j.eclinm.2024.102472. eCollection 2024 Mar. EClinicalMedicine. 2024. PMID: 38361992 Free PMC article.
A recurrent pleuropneumonia revealing Erdheim-Chester Disease.
Kherabi Y, Chazal T, Emile JF, Allaham W, Mallart E, de Lastours V, Haroche J, Nguyen Y. Kherabi Y, et al. Among authors: de lastours v. Respir Med Case Rep. 2023 Apr 7;43:101843. doi: 10.1016/j.rmcr.2023.101843. eCollection 2023. Respir Med Case Rep. 2023. PMID: 37091897 Free PMC article.
The bacterial genetic determinants of Escherichia coli capacity to cause bloodstream infections in humans.
Burgaya J, Marin J, Royer G, Condamine B, Gachet B, Clermont O, Jaureguy F, Burdet C, Lefort A, de Lastours V, Denamur E, Galardini M, Blanquart F; Colibafi/Septicoli & Coliville groups. Burgaya J, et al. Among authors: de lastours v. PLoS Genet. 2023 Aug 2;19(8):e1010842. doi: 10.1371/journal.pgen.1010842. eCollection 2023 Aug. PLoS Genet. 2023. PMID: 37531401 Free PMC article.
Efficacy of vancomycin lock therapy for totally implantable venous access port-related infection due to coagulase-negative staphylococci in 100 patients with cancer.
Lafaurie M, Montlahuc C, Kerneis S, de Lastours V, Abgrall S, Manceron V, Couzigou C, Chabrol A, de Raigniac A, Lescure X, Longuet P, Lesprit P, Vanjak D, Lepeule R; Groupe des référents en Infectiologie d’Ile de France (GRIF). Lafaurie M, et al. Among authors: de lastours v. J Antimicrob Chemother. 2023 May 3;78(5):1253-1258. doi: 10.1093/jac/dkad083. J Antimicrob Chemother. 2023. PMID: 37014800
Contribution of Clinical Metagenomics to the Diagnosis of Bone and Joint Infections.
d'Humières C, Gaïa N, Gueye S, de Lastours V, Leflon-Guibout V, Maataoui N, Duprilot M, Lecronier M, Rousseau MA, Gamany N, Lescure FX, Senard O, Deconinck L, Dollat M, Isernia V, Le Hur AC, Petitjean M, Nazimoudine A, Le Gac S, Chalal S, Ferreira S, Lazarevic V, Guigon G, Gervasi G, Armand-Lefèvre L, Schrenzel J, Ruppé E. d'Humières C, et al. Among authors: de lastours v. Front Microbiol. 2022 Apr 21;13:863777. doi: 10.3389/fmicb.2022.863777. eCollection 2022. Front Microbiol. 2022. PMID: 35531285 Free PMC article.
67 results